ERBB2 and breast cancer: In this study, qRT-PCR experiments validated that specific siRNA can silence circCDYL, which can consistently decrease or increase circCDYL in HER2+BC cells; overexpression of circCDYL promotes activation of the PI3K/AKT pathway in SK-RB-3 cells.